- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Soft tissue
Dr Shane Zaidi is a Consultant Clinical Oncologist specialising in the treatment of sarcoma and skin cancers. He has both a private and NHS practice at The Royal Marsden.
He qualified from St George’s Hospital Medical School, University of London in 1998 and trained in oncology at The Royal Marsden and in North East Thames. Between 2007-2010 Dr Zaidi was a Clinical Research Fellow for Cancer Research UK and completed his PhD in combining new anti-cancer agents with radiation at the Institute of Cancer Research.
After finishing specialist oncological training in 2012, he completed a 20-month post-doctoral fellowship in molecular medicine at The Mayo Clinic, Minnesota, combining radiation with new immunotherapy agents. He returned to the UK in January 2015 and became a Consultant Clinical Oncologist in the Sarcoma Unit, and was subsequently appointed at The Royal Marsden and St George's in 2017.
Dr Zaidi is actively involved in clinical research with a particular interest in integrating novel biological therapies (including immunotherapy) into radiotherapy treatment for sarcomas.
Areas of interest
Radiotherapy including IMRT, IGRT and CyberKnife for soft tissue sarcomas. Chemotherapy for soft tissue sarcomas. Radiotherapy for skin cancers.
Reference number 4555078
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)
Delivery of a fraction of Intensity Modulated Radiotherapy (IMRT) using RapidArc - (1-5)
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)
- Show All (8 )...